173 related articles for article (PubMed ID: 12848593)
1. Posaconazole: SCH 56592.
Adis International Ltd
Drugs R D; 2003; 4(4):258-63. PubMed ID: 12848593
[TBL] [Abstract][Full Text] [Related]
2. Posaconazole: an extended-spectrum triazole antifungal agent.
Schiller DS; Fung HB
Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
[TBL] [Abstract][Full Text] [Related]
3. Posaconazole.
Keating GM
Drugs; 2005; 65(11):1553-67; discussion 1568-9. PubMed ID: 16033292
[TBL] [Abstract][Full Text] [Related]
4. Posaconazole: a broad-spectrum triazole antifungal.
Torres HA; Hachem RY; Chemaly RF; Kontoyiannis DP; Raad II
Lancet Infect Dis; 2005 Dec; 5(12):775-85. PubMed ID: 16310149
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole : a review of its use in the management of invasive fungal infections.
Scott LJ; Simpson D
Drugs; 2007; 67(2):269-98. PubMed ID: 17284090
[TBL] [Abstract][Full Text] [Related]
6. Novel triazole antifungal agents.
Hoffman HL; Ernst EJ; Klepser ME
Expert Opin Investig Drugs; 2000 Mar; 9(3):593-605. PubMed ID: 11060698
[TBL] [Abstract][Full Text] [Related]
7. Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
Groll AH; Walsh TJ
Mycoses; 2006; 49 Suppl 1():7-16. PubMed ID: 16961576
[TBL] [Abstract][Full Text] [Related]
8. Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.
Herbrecht R
Int J Clin Pract; 2004 Jun; 58(6):612-24. PubMed ID: 15311563
[TBL] [Abstract][Full Text] [Related]
9. Posaconazole: a new broad-spectrum antifungal agent.
Kwon DS; Mylonakis E
Expert Opin Pharmacother; 2007 Jun; 8(8):1167-78. PubMed ID: 17516880
[TBL] [Abstract][Full Text] [Related]
10. Posaconazole.
Dodds Ashley ES; Alexander BD
Drugs Today (Barc); 2005 Jun; 41(6):393-400. PubMed ID: 16110346
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304.
Anaissie EJ; Kontoyiannis DP; Vartivarian S; Kantarjian HM; O'Brien S; Giralt SA; Andersson BS; Karl C; Champlin RE; Bodey GP
Clin Infect Dis; 1993 Dec; 17(6):1022-31. PubMed ID: 8110925
[TBL] [Abstract][Full Text] [Related]
12. Posaconazole.
Bhattacharya M; Rajeshwari K; Dhingra B
J Postgrad Med; 2010; 56(2):163-7. PubMed ID: 20622401
[TBL] [Abstract][Full Text] [Related]
13. [The latest data on posaconazole].
Paugam A
Med Mal Infect; 2007 Feb; 37(2):71-6. PubMed ID: 17267154
[TBL] [Abstract][Full Text] [Related]
14. Posaconazole: an oral triazole with an extended spectrum of activity.
Rachwalski EJ; Wieczorkiewicz JT; Scheetz MH
Ann Pharmacother; 2008 Oct; 42(10):1429-38. PubMed ID: 18713852
[TBL] [Abstract][Full Text] [Related]
15. Posaconazole prophylaxis in hematologic cancer.
Kontoyiannis DP; Lewis RE
N Engl J Med; 2007 May; 356(21):2214-5; author reply 2215-8. PubMed ID: 17526090
[No Abstract] [Full Text] [Related]
16. Clinical efficacy of new antifungal agents.
Kauffman CA
Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366
[TBL] [Abstract][Full Text] [Related]
17. Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.
Clark NM; Grim SA; Lynch JP
Semin Respir Crit Care Med; 2015 Oct; 36(5):767-85. PubMed ID: 26398542
[TBL] [Abstract][Full Text] [Related]
18. [Antifungal therapy update: new drugs and medical uses].
Fortún J
Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():38-44. PubMed ID: 22305668
[TBL] [Abstract][Full Text] [Related]
19. SCH 56592.
Drugs R D; 1999 Feb; 1(2):184-6. PubMed ID: 10566022
[No Abstract] [Full Text] [Related]
20. Posaconazole: clinical pharmacology and potential for management of fungal infections.
Groll AH; Walsh TJ
Expert Rev Anti Infect Ther; 2005 Aug; 3(4):467-87. PubMed ID: 16107193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
